Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SLU-PP-1072 | 2285432-57-5 | C18H12N2O3S | 25 MG
SDP

Catalog No. 5000375564
Encompass_Preferred

SLU-PP-1072 is a dual ERRα/γ inverse agonist identified for its role in prostate cancer (PCa) research. This compound functions by disrupting PCa cell metabolism and inducing apoptosis through the dysregulation of the cell cycle. It acts as a selective inverse agonist for ERRα and ERRγ, making it a preclinical tool for targeting ERRα/γ-driven cancer metabolism.

  • Acts as a dual ERRα/γ inverse agonist.
  • Used in prostate cancer (PCa) research.
  • Disrupts PCa cell metabolism.
  • Induces apoptosis by dysregulating the cell cycle.
  • Selective for ERRα/γ.
  • Inhibits the Warburg effect.

Catalog No. 50-003-75564 Supplier Medchemexpress LLC Supplier No. 25MGHY153895
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SLU-PP-1072 is a dual ERRα/γ inverse agonist identified for its role in prostate cancer (PCa) research. This compound functions by disrupting PCa cell metabolism and inducing apoptosis through the dysregulation of the cell cycle. It acts as a selective inverse agonist for ERRα and ERRγ, making it a preclinical tool for targeting ERRα/γ-driven cancer metabolism.

  • Acts as a dual ERRα/γ inverse agonist.
  • Used in prostate cancer (PCa) research.
  • Disrupts PCa cell metabolism.
  • Induces apoptosis by dysregulating the cell cycle.
  • Selective for ERRα/γ.
  • Inhibits the Warburg effect.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.